ELP, Desai Diwanji lead on Piramal Pharma Solutions acquisition of Hemmo Pharmaceuticals for ₹775 crore

After the acquisition, Hemmo Pharma will become the wholly-owned subsidiary of Piramal Pharma.
ELP, Desai Diwanji lead on Piramal Pharma Solutions acquisition of Hemmo Pharmaceuticals for ₹775 crore
Medicines

Piramal Pharma Solutions (PPS) is acquiring a 100% stake in Hemmo Pharmaceuticals Pvt Ltd for ₹775 crore.

Subscribe now to get unlimited access

We're glad you're enjoying Bar and Bench - Indian Legal news. Login and subscribe to continue reading this story.

Already a user? Login
No stories found.
Bar and Bench - Indian Legal news
www.barandbench.com